487 related articles for article (PubMed ID: 17494697)
1. CHIP overexpression reduces mutant androgen receptor protein and ameliorates phenotypes of the spinal and bulbar muscular atrophy transgenic mouse model.
Adachi H; Waza M; Tokui K; Katsuno M; Minamiyama M; Tanaka F; Doyu M; Sobue G
J Neurosci; 2007 May; 27(19):5115-26. PubMed ID: 17494697
[TBL] [Abstract][Full Text] [Related]
2. Heat shock protein 70 chaperone overexpression ameliorates phenotypes of the spinal and bulbar muscular atrophy transgenic mouse model by reducing nuclear-localized mutant androgen receptor protein.
Adachi H; Katsuno M; Minamiyama M; Sang C; Pagoulatos G; Angelidis C; Kusakabe M; Yoshiki A; Kobayashi Y; Doyu M; Sobue G
J Neurosci; 2003 Mar; 23(6):2203-11. PubMed ID: 12657679
[TBL] [Abstract][Full Text] [Related]
3. 17-DMAG ameliorates polyglutamine-mediated motor neuron degeneration through well-preserved proteasome function in an SBMA model mouse.
Tokui K; Adachi H; Waza M; Katsuno M; Minamiyama M; Doi H; Tanaka K; Hamazaki J; Murata S; Tanaka F; Sobue G
Hum Mol Genet; 2009 Mar; 18(5):898-910. PubMed ID: 19066230
[TBL] [Abstract][Full Text] [Related]
4. Loss of endogenous androgen receptor protein accelerates motor neuron degeneration and accentuates androgen insensitivity in a mouse model of X-linked spinal and bulbar muscular atrophy.
Thomas PS; Fraley GS; Damian V; Woodke LB; Zapata F; Sopher BL; Plymate SR; La Spada AR
Hum Mol Genet; 2006 Jul; 15(14):2225-38. PubMed ID: 16772330
[TBL] [Abstract][Full Text] [Related]
5. 17-AAG, an Hsp90 inhibitor, ameliorates polyglutamine-mediated motor neuron degeneration.
Waza M; Adachi H; Katsuno M; Minamiyama M; Sang C; Tanaka F; Inukai A; Doyu M; Sobue G
Nat Med; 2005 Oct; 11(10):1088-95. PubMed ID: 16155577
[TBL] [Abstract][Full Text] [Related]
6. Spinal and bulbar muscular atrophy: ligand-dependent pathogenesis and therapeutic perspectives.
Katsuno M; Adachi H; Tanaka F; Sobue G
J Mol Med (Berl); 2004 May; 82(5):298-307. PubMed ID: 15133611
[TBL] [Abstract][Full Text] [Related]
7. Molecular chaperones enhance the degradation of expanded polyglutamine repeat androgen receptor in a cellular model of spinal and bulbar muscular atrophy.
Bailey CK; Andriola IF; Kampinga HH; Merry DE
Hum Mol Genet; 2002 Mar; 11(5):515-23. PubMed ID: 11875046
[TBL] [Abstract][Full Text] [Related]
8. Transgenic mouse models of spinal and bulbar muscular atrophy (SBMA).
Katsuno M; Adachi H; Inukai A; Sobue G
Cytogenet Genome Res; 2003; 100(1-4):243-51. PubMed ID: 14526186
[TBL] [Abstract][Full Text] [Related]
9. Widespread nuclear and cytoplasmic accumulation of mutant androgen receptor in SBMA patients.
Adachi H; Katsuno M; Minamiyama M; Waza M; Sang C; Nakagomi Y; Kobayashi Y; Tanaka F; Doyu M; Inukai A; Yoshida M; Hashizume Y; Sobue G
Brain; 2005 Mar; 128(Pt 3):659-70. PubMed ID: 15659427
[TBL] [Abstract][Full Text] [Related]
10. Cytoplasmic retention of polyglutamine-expanded androgen receptor ameliorates disease via autophagy in a mouse model of spinal and bulbar muscular atrophy.
Montie HL; Cho MS; Holder L; Liu Y; Tsvetkov AS; Finkbeiner S; Merry DE
Hum Mol Genet; 2009 Jun; 18(11):1937-50. PubMed ID: 19279159
[TBL] [Abstract][Full Text] [Related]
11. [Development of therapeutics for spinal and bulbar muscular atrophy (SBMA)].
Sobue G
Rinsho Shinkeigaku; 2003 Nov; 43(11):909-11. PubMed ID: 15152501
[TBL] [Abstract][Full Text] [Related]
12. [Study of androgen receptor expression and neuronal vulnerability in X-linked spinal and bulbar muscular atrophy].
Matsuura T
Hokkaido Igaku Zasshi; 1996 Nov; 71(6):785-99. PubMed ID: 8996845
[TBL] [Abstract][Full Text] [Related]
13. p62/SQSTM1 differentially removes the toxic mutant androgen receptor via autophagy and inclusion formation in a spinal and bulbar muscular atrophy mouse model.
Doi H; Adachi H; Katsuno M; Minamiyama M; Matsumoto S; Kondo N; Miyazaki Y; Iida M; Tohnai G; Qiang Q; Tanaka F; Yanagawa T; Warabi E; Ishii T; Sobue G
J Neurosci; 2013 May; 33(18):7710-27. PubMed ID: 23637164
[TBL] [Abstract][Full Text] [Related]
14. [Triplet repeat disease, with particular emphasis of spinal and bulbar muscular atrophy (SBMA)].
Sobue G
Rinsho Shinkeigaku; 2000 Dec; 40(12):1193-5. PubMed ID: 11464455
[TBL] [Abstract][Full Text] [Related]
15. Pathogenesis and molecular targeted therapy of spinal and bulbar muscular atrophy.
Adachi H; Waza M; Katsuno M; Tanaka F; Doyu M; Sobue G
Neuropathol Appl Neurobiol; 2007 Apr; 33(2):135-51. PubMed ID: 17359355
[TBL] [Abstract][Full Text] [Related]
16. Genistein, a natural product derived from soybeans, ameliorates polyglutamine-mediated motor neuron disease.
Qiang Q; Adachi H; Huang Z; Jiang YM; Katsuno M; Minamiyama M; Doi H; Matsumoto S; Kondo N; Miyazaki Y; Iida M; Tohnai G; Sobue G
J Neurochem; 2013 Jul; 126(1):122-30. PubMed ID: 23363377
[TBL] [Abstract][Full Text] [Related]
17. Silencing neuronal mutant androgen receptor in a mouse model of spinal and bulbar muscular atrophy.
Sahashi K; Katsuno M; Hung G; Adachi H; Kondo N; Nakatsuji H; Tohnai G; Iida M; Bennett CF; Sobue G
Hum Mol Genet; 2015 Nov; 24(21):5985-94. PubMed ID: 26231218
[TBL] [Abstract][Full Text] [Related]
18. Neuropathology and therapeutic intervention in spinal and bulbar muscular atrophy.
Banno H; Katsuno M; Suzuki K; Tanaka F; Sobue G
Int J Mol Sci; 2009 Mar; 10(3):1000-12. PubMed ID: 19399234
[TBL] [Abstract][Full Text] [Related]
19. [Molecular pathogenesis of motor neuron diseases].
Sobue G
Nihon Shinkei Seishin Yakurigaku Zasshi; 2001 Feb; 21(1):21-25. PubMed ID: 11400322
[TBL] [Abstract][Full Text] [Related]
20. Androgen receptor YAC transgenic mice recapitulate SBMA motor neuronopathy and implicate VEGF164 in the motor neuron degeneration.
Sopher BL; Thomas PS; LaFevre-Bernt MA; Holm IE; Wilke SA; Ware CB; Jin LW; Libby RT; Ellerby LM; La Spada AR
Neuron; 2004 Mar; 41(5):687-99. PubMed ID: 15003169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
